Cargando…
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study
BACKGROUND: Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associated with a high risk for melanoma. Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes, and some variants of the melanocortin-1 receptor gene (MC1R), which is...
Autores principales: | Demenais, F., Mohamdi, H., Chaudru, V., Goldstein, A. M., Newton Bishop, J. A., Bishop, D. T., Kanetsky, P. A., Hayward, N. K., Gillanders, E., Elder, D. E., Avril, M. F., Azizi, E., van Belle, P., Bergman, W., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Carrera, C., Hansson, J., Harland, M., Hogg, D., Höiom, V., Holland, E. A., Ingvar, C., Landi, M. T., Lang, J. M., Mackie, R. M., Mann, G. J., Ming, M. E., Njauw, C. J., Olsson, H., Palmer, J., Pastorino, L., Puig, S., Randerson-Moor, J., Stark, M., Tsao, H., Tucker, M. A., van der Velden, P., Yang, X. R., Gruis, N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957428/ https://www.ncbi.nlm.nih.gov/pubmed/20876876 http://dx.doi.org/10.1093/jnci/djq363 |
Ejemplares similares
-
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia
por: Dalmasso, B., et al.
Publicado: (2021) -
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study
por: Davies, John R, et al.
Publicado: (2012) -
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study
por: Davies, John R, et al.
Publicado: (2014) -
Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposure
por: Cust, A.E., et al.
Publicado: (2019) -
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not
por: Langers, A M J, et al.
Publicado: (2008)